Learn about Xultophy® 100/3.6, a basal insulin & GLP-1 RA in one injection, for adults with type 2 diabetes as an adjunct to diet and exercise. Read Safety Information including Boxed Warning.

2024年5月1日 · Xultophy is an injection pen containing a combination of insulin degludec and liraglutide. Insulin degludec is a long-acting insulin that starts to work several hours after injection and keeps working evenly for 24 hours.

Xultophy ® 100/3.6 is an injectable prescription medicine made up of 2 proven medicines in 1 pen to lower blood sugar for 24 hours along with diet and exercise in adults with type 2 diabetes. It adds insulin when your body isn’t making enough to lower blood sugar throughout the day.

2024年7月31日 · Xultophy works in several ways to help keep your blood sugar levels from getting too high. It causes your pancreas to release more insulin after you eat, absorbs sugar from the...

XULTOPHY 100/3.6 is a combination of insulin degludec, a long-acting human insulin analog, and liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist, indicated as an adjunct to diet...

2.1 Important Dosage Information - • XULTOPHY 100/3.6 is a combination of insulin degludec and liraglutide. • Administer XULTOPHY 100/3.6 by subcutaneous injection once-daily at the same time ...

Insulin degludec/liraglutide, sold under the brand name Xultophy, is a fixed-dose combination medication for the treatment of adults with type 2 diabetes to improve glycemic control in combination with diet and exercise. [7][8] It contains insulin degludec and liraglutide. [7][8] It is administered by subcutaneous injection. [7][8]

Xultophy ® 100/3.6 (insulin degludec and liraglutide) injection 100 units/mL and 3.6 mg/mL is a combination of insulin degludec and liraglutide and is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

2024年12月16日 · Xultophy is used to manage blood sugar levels in adults with Type 2 diabetes. It's a premixed injection that combines two medications: insulin degludec (a long-acting insulin) and liraglutide (a glucagon-like peptide-1 (GLP-1) agonist). It works best when used along with a healthy diet and regular exercise.

2023年6月21日 · Xultophy 100/3.6 is a combination of insulin degludec, a long-acting human insulin analog, and liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist, indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus inadequately controlled on basal insulin (less than 50 units daily) or lir...